Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Different γδ T cell types have unique roles in causing alopecia areata.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

PDCD4 is important for controlling skin cell growth and healing.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

CD98hc's role in skin health decreases with age.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Keratins 8 and 14 can help identify and diagnose benign skin tumors.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

The study identified key immune cell differences between mild and severe alopecia areata.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Seven genes are highly expressed in both germ-line and hematopoietic stem cells.